Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170011/S061

Impella RP System, Impella RP with Smart Assist System, Impella RP Flex System

Abiomed, Inc. · Decision date Feb 6, 2026

FDA DECISIONP170011/S061

What did the FDA approve?

FDA records P170011/S061 as a supplement to PMA P170011, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Feb 6, 2026.

FDA approval order statement

approval for a modification to the Instructions for Use to allow sodium bicarbonate to be used in the purge fluid for the Impella catheters if heparin should not be used per the physicians clinical judgement.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Feb 6, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P170011/S061
Regulatory pathway
PMA supplement
Applicant
Abiomed, Inc.
Product code
PYX
Decision code
APPR
Decision date
Feb 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Temporary non-roller type right heart support blood pump.

Applicant
Abiomed, Inc.
Product code
PYX
FDA device class
3

For the original device and its historical approval scope, see PMA P170011. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170011 · Original PMA

    Impella RP System

  2. P170011/S059 · Related supplement

    Impella RP, Impella RP with SmartAssist, and Impella RP Flex with SmartAssist

  3. P170011/S056 · Related supplement

    Impella RP System; Impella RP with SmartAssist System; Impella RP Flex with SmartAssist System;

  4. P170011/S060 · Related supplement

    Impella RP, Impella RP with SmartAssist, Impella RP Flex with SmartAssist

  5. P170011/S061 received

    Application receipt date recorded by FDA.

  6. P170011/S062 · Related supplement

    Impella CP with SmartAssist; Impella 5.5 with SmartAssist

  7. P170011/S061 · FDA decision

    Real-Time Process

  8. P170011/S064 · Related supplement

    Impella RP Flex with SmartAssist

Timeline entries are records held by MedtechLedger for P170011. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170011

Product / regulatory recordCompanyPathwayDecision dateSource
Abiomed, Inc.PMA approvalSep 20, 2017FDA
Abiomed, Inc.PMA supplementJul 25, 2025FDA
Abiomed, Inc.PMA supplementAug 1, 2025FDA
Purge CassetteP170011/S058
Abiomed, Inc.PMA supplementSep 15, 2025FDA
Abiomed, Inc.PMA supplementSep 19, 2025FDA
Abiomed, Inc.PMA supplementDec 19, 2025FDA
Impella RP SystemP170011/S063
Abiomed, Inc.PMA supplementApr 1, 2026FDA
Abiomed, Inc.PMA supplementOct 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abiomed, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
22 Cherry Hill Dr., Danvers, MA, 01923

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records